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Gene Expression Profiling of Islet Cell Subtypes 
David Blodgett, Susanne Pechhold, Klaus Pechhold, and David Harlan 
University of Massachusetts Medical School Department of Medicine – Diabetes Division 
Pancreatic endocrine cells are co-located into clusters called the islets of 
Langerhans that are comprised of glucagon producing alpha cells, insulin 
secreting beta cells, somatostatin generating delta cells, and other cell 
types.  Type 1 diabetes results from an autoimmune process in which 
autoreactive T cells destroy the insulin producing beta cells, requiring the 
patient to inject insulin to regulate their blood glucose levels. Thus far, 
attempts to cure diabetes via islet transplantation have been limited by 
insufficient donor supply, inconsistent isolated islet quality, continued 
autoimmunity, alloimmune rejection, and limited beta cell regeneration. 
Diabetes research has focused on preventing the autoimmune response, 
promoting stem cell to beta cell differentiation, and defining the factors that 
influence beta cell proliferation. Islet research, in turn, has been limited to 
whole islet studies since, isolating the islet cell subtypes has not been 
possible. Using a method recently developed for mouse islet cells (Pechhold 
et al. Nat Biotechnol. 2009 Nov; 27(11):1038-42), that uses intracellular 
hormone staining and flow cytometry, we are able to sort human islets into 
populations uniquely expressing glucagon, insulin, or somatostatin. Further, 
we have developed a human gene array to measure candidate gene 
expression using a quantitative nuclease protection assay (qNPA). This 
technique uses 50 base oligomers that specifically recognize RNA from each 
gene of interest, overcoming limitations caused by the harsh conditions 
required for intracellular staining. We report gene expression analysis for 
specific hormones and transcription factors expressed in each islet cell 
population. We are further modifying this technique to study nonhuman 
primate islets, and investigate the specific proteome and miRNA profiles for 
individual islet cell populations. The goal of these studies is to characterize 
the genetic differences between the islet cell populations and understand 
which factors control beta cell regeneration and proliferation. 
Pancreatic Islet Architecture & Cell Purification 
Abstract 
The adult human islet is comprised of alpha, beta, and delta cells. The cells 
are dispersed in a heterogenous manner throughout the islet.  
Figure 1: Islet Cell Purification Flowchart. We dissociate human islets into 
a single cell suspension, fix and permeabilize the cells with PFA and 
saponin, respectively, stain for intracellular hormones using insulin, 
glucagon, and somatostatin antibodies that are either pre-labeled or are 
recognized by secondary antibodies conjugated to fluorescent probes. The 
dissociated and stained islets are sorted into individual cell types using 
fluorescence activated cell sorting technology.  
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Flow Cytometry Gating Strategy 
Isolated Pancreatic Islets 
(Brissova M et al. J Histochem 
Cytochem 2005;53:1087-1097) 
Islets are dissociated into a 
single cell suspension using 
EDTA and trypsin 
Ins Ab (gp) 
APC Anti-gp 
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Gcg Ab (+ Zenon Pac Blue) 
Sst Ab  
(+ Zenon AF 488) 
Cells are fixed (PFA – prevents 
cytoplasmic hormones from 
leaving the cell following 
permeabilization), permeabilized 
(saponin – to give antibodies 
access to intracellular 
components), and stained. 
Cells are purified into individual 
populations based upon 
intracellular hormone content 
using fluorescence-activated cell 
sorting. 
Figure 2: Sorting Alpha, Beta, and Delta Cells. The gating hierarchy (A) 
and strategy (B-E): viable cells are selected by gating out debris (low fsc) 
and VRC nonspecific fluorophore binding (VRC is pre-incubated with PE and 
high PE labeling is gated out B-C). Each hormone expressing cell population 
is then gated (insulin = APC (D); glucagon = Pacific Blue (E); somatostatin = 
488 (E)), doublets are excluded per the FSC-Height v. FSC-Area plot (F-H) 
and a final sort gate is generated by plotting fluorophore of interest versus 
the remaining nonspecific fluorophore (I-K). Note the insulin (red) cells have 
the highest side scatter, due to their granular nature (L). Following sorting, a 
small amount of sorted insulin cells were reanalyzed to determine if the cells 
have been properly sorted and are only insulin positive. Cells only appear in 
the initial insulin gate, within the singlet gate, and within the sort gate. All 
other debris and non-insulin expressing cells have been excluded. These 
sorted cells provide the mRNA that will be used in the qNPA arrays to 
measure gene expression within each islet cell subtype. 
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qNPA Methodolgy 
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Figure 3: qNPA Setup. Two part preparation: (A = sample preparation) fixed 
and sorted cells are incubated with gene specific 50-mer probes, S1 
nuclease digests unbound probes and mRNA. The remaining gene specific 
probes are transferred to the qNPA plate. (B = plate preparation) each 96-
well has a 4x4 grid map printed on it. Each spot within the well corresponds 
to a specific gene and is programmed with linkers that recognize one of the 
sixteen respective spots. The sample qNPA probe is added and binds to the 
programming linker. The detection linker hybridizes to the probe and the 
detection probe binds to it. After incubation with HRP substrate, photons are 
measured as an indicator of signal intensity. 
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Sorted Islets Gene Expression Profiles 
Figure 4: qNPA Results. Three human donor samples were sorted and 
purified alpha and beta cell populations (as well as a population that did not 
stain for insulin, glucagon, or somatostatin) were assessed for their gene 
expression profiles. HI10-10 = male, age 48, BMI 34.4; HI11-2 = female, age 
55, BMI 31.6; HI11-6 = unknown gender, age 66, BMI 34, diagnosed T2DM. 
Insulin and glucagon were highly expressed in beta and alpha cells, 
respectively, while glucagon mRNA is also detected in purified beta cells. 
Conclusions 
We have shown that we can purify adult human islets into individual cellular 
populations. This is the first step in understanding the genetic and 
environmental components that regulate increased beta cell proliferation and 
beta cell mass. In the absence of full-length mRNA for RT-PCR or next 
generation sequencing, the qNPA technique provides candidate gene 
expression profiles for these cells. 
